Diagnosis and Management of Patients with the α-Gal Syndrome
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The α-Gal syndrome has many novel features that are relevant to diagnosis and management. In most cases the diagnosis can be made on a history of delayed allergic reactions to red meat and the blood test for IgE to the oligosaccharide galactose-α−1,3-galactose (α-Gal). In general, the diagnosis also dictates the primary treatment, i.e. – avoiding mammalian meat and also dairy in some cases. In the USA the lone star tick is the primary cause of this disease but different ticks are responsible in other countries. Blood levels of IgE to α-Gal often drop in patients who avoid recurrent tick bites, but the rate of decline is variable. Similarly, the delay before reactions is variable and the severity of the allergic reactions is not predicted by the delay or the titer of specific IgE. Some mammalian-derived products are only relevant to select patient groups, such as heart valves, gelatin-based plasma expanders, and pancreatic enzymes. A minority of cases may benefit from avoiding a wide range of products that are prepared with mammalian–derived constituents, such as gelatin. This review focuses on the nature of the syndrome, common challenges in diagnosis and management, and also gaps in our current knowledge that would benefit from additional investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Self-citationCommins, S. P., James, H. R., Kelly, L. A., Pochan, S. L., Workman, L. J., Perzanowski, M. S., Kocan, K. M., Fahy, J. V., Nganga, L. W., Ronmark, E., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.02.019 · Cited by 642
Self-citationRelationship between red meat allergy and sensitization to gelatin and galactose-α-1,3-galactose
Mullins, R. J., James, H., Platts-Mills, T. A. E., & Commins, S. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.038 · Cited by 260 · cited 2×
“Gelatin is used as a plasma expander in some countries, particularly Australia and the United Kingdom.(49,66) Gelafundin is one such plasma expander; in fact, it has been used by some groups when skin testing for a-Gal.”
MethodSelf-citation
Cited by
World Allergy Organization Anaphylaxis Guidance 2020
Cardona, V., Ansotegui, I. J., Ebisawa, M., El-Gamal, Y., Fernandez Rivas, M., Fineman, S., Geller, M., Gonzalez-Estrada, A., Greenberger, P. A., Sanchez Borges, M., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2020.100472 · Cited by 1,186
EAACI Molecular Allergology User's Guide 2.0
Dramburg, S., Hilger, C., Santos, A. F., de las Vecillas, L., Aalberse, R. C., Acevedo, N., Aglas, L., Altmann, F., Arruda, K. L., Asero, R., et al. (2023) · Pediatric Allergy and Immunology · doi:10.1111/pai.13854 · Cited by 298
Self-citationManagement of Food Allergies and Food-Related Anaphylaxis
Iglesia, E. G. A., Kwan, M., Virkud, Y. V., & Iweala, O. I. (2024) · JAMA · doi:10.1001/jama.2023.26857 · Cited by 89
The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome
Macdougall, J. D., Thomas, K. O., & Iweala, O. I. (2022) · ImmunoTargets and Therapy · doi:10.2147/itt.s276872 · Cited by 64
The Possible Role of Anti-Neu5Gc as an Obstacle in Xenotransplantation
Tector, A. J., Mosser, M., Tector, M., & Bach, J.-M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00622 · Cited by 60
“Anti-Gal antibodies have been shown to mediate an inflammatory calcification of bioprosthetic heart valves (87, 88) and have been implicated in their deterioration (89, 90).”
BackgroundCurrent and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS)
Vaz-Rodrigues, R., Mazuecos, L., & de la Fuente, J. (2022) · Journal of Asthma and Allergy · doi:10.2147/jaa.s265660 · Cited by 53
The α-Gal epitope - the cause of a global allergic disease
Perusko, M., Grundström, J., Eldh, M., Hamsten, C., Apostolovic, D., & van Hage, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1335911 · Cited by 52
Extrinsic and Intrinsic Modulators of Anaphylaxis
Carter, M. C., Park, J., Vadas, P., & Worm, M. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.05.015 · Cited by 17
Metadata
- Authors
- Platts-Mills, T. A. E., Li, R.-C., Keshavarz, B., Smith, A. R., & Wilson, J. M.
- Venue
- The Journal of Allergy and Clinical Immunology: In Practice
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 8
- Issue
- 1
- Pages
- 15-23.e1
- ISSN
- 2213-2198 (ISSN-L)
- OpenAlex
- W2976485244
- Cited by
- 197
- References
- 3
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.